Wesley Day

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

Kishore M. Gadde, David B. Allison, Donna H. Ryan et al. · The Lancet · 2011 · 1K citations

Obesity, Health Policy, Topiramate Combination +7

Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)

David B. Allison, Kishore M. Gadde, W. Timothy Garvey et al. · Obesity · 2011 · 703 citations

Nutrition, Bariatric Surgery, Class Ii +18

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

W. Timothy Garvey, Donna H. Ryan, Michelle Look et al. · American Journal of Clinical Nutrition · 2011 · 691 citations · Full text

Obesity, Metabolic Syndrome, Nutrition +11

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release

W. Timothy Garvey, Donna H. Ryan, Robert R. Henry et al. · Diabetes Care · 2013 · 206 citations · Full text

Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene

Michael R. McClung, Ethel S. Siris, Steve Cummings et al. · Menopause The Journal of The North American Menopause Society · 2006 · 109 citations